Hamid Mirzaei
@hamidmirzaei81.bsky.social
Cancer immunologist and Senior Research Scientist at MD Anderson Cancer Center @mdanderson.bsky.social
Excited to share our paper that has been published in the @journalofnucmed.bsky.social
jnm.snmjournals.org/content/earl...
Our findings demonstrate the feasibility of PET-based CAR-T cell tracking in a solid tumor model through selective DOTA-hapten and Thor platform. #cartcells #immunotherapy
jnm.snmjournals.org/content/earl...
Our findings demonstrate the feasibility of PET-based CAR-T cell tracking in a solid tumor model through selective DOTA-hapten and Thor platform. #cartcells #immunotherapy
jnm.snmjournals.org
January 4, 2026 at 4:59 AM
Excited to share our paper that has been published in the @journalofnucmed.bsky.social
jnm.snmjournals.org/content/earl...
Our findings demonstrate the feasibility of PET-based CAR-T cell tracking in a solid tumor model through selective DOTA-hapten and Thor platform. #cartcells #immunotherapy
jnm.snmjournals.org/content/earl...
Our findings demonstrate the feasibility of PET-based CAR-T cell tracking in a solid tumor model through selective DOTA-hapten and Thor platform. #cartcells #immunotherapy